AstraZeneca Pharma India Reports 30% Revenue Growth to Rs 7,291 Million
The company reported year-on-year revenue growth from operations in the second quarter; the supplied body says growth was driven by performance across oncology, biopharmaceuticals and rare diseases, regulatory approvals and state-level healthcare partnerships.
Strong performance across oncology, biopharmaceuticals and rare diseases, alongside regulatory approvals and state-level healthcare partnerships, drives growthAstraZeneca Pharma India Limited reported a 30 per cent year-on-year growth in revenue from operations to Rs 7,291 million in the second qua…